#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5730	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2032	540.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1387	1387	C	679	C,G	443,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11404	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3941	550.4	0	.	n	.	0	T695C	SNP	695	695	T	1292	1292	C	748	C,T,A	482,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11404	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3941	550.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1934	1934	A	631	A,C	403,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11404	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3941	550.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2568	2568	C	659	C,G	423,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11404	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3941	550.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2642	2642	A	596	A	389	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	11404	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3941	550.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3194	3194	C	816	C,T	552,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	518	folP	852	852	100.0	folP.l15.c4.ctg.1	1778	58.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1161	1163	AGC	79;79;79	A,T,G;G;C	54,1,1;56;55	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3492	84.2	1	SNP	p	S91F	0	.	.	271	273	TCC	494	496	TCC	99;99;99	T;C;C	62;64;65	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3492	84.2	1	SNP	p	D95G	0	.	.	283	285	GAC	506	508	GAC	98;98;98	G;A;C	67;67;67	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3492	84.2	1	SNP	p	D95N	0	.	.	283	285	GAC	506	508	GAC	98;98;98	G;A;C	67;67;67	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	464	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1469	65.0	0	.	p	.	0	A39T	NONSYN	115	117	GCC	487	489	ACC	134;134;134	A;C;C	82;81;82	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	464	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1469	65.0	0	.	p	.	0	R44H	NONSYN	130	132	CGC	502	504	CAC	133;133;133	C;A;C	86;83;85	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	464	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1469	65.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	685	687	CAC	112;113;114	C;A,C;C	83;83,1;84	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	464	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1469	65.0	1	SNP	p	G45D	0	.	.	133	135	GGC	505	507	GGC	133;134;134	G,A;G;C	82,1;86;84	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	398	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	991	75.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	283	1484	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3039	91.7	1	SNP	p	D86N	0	.	.	256	258	GAC	2337	2339	CTG	134;134;134	C,A;T;G	87,1;81;84	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	283	1484	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3039	91.7	1	SNP	p	S87W	0	.	.	259	261	AGT	2334	2336	TCA	133;134;135	T;C;A,C	79;84;89,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	283	1484	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3039	91.7	1	SNP	p	S87R	0	.	.	259	261	AGT	2334	2336	TCA	133;134;135	T;C;A,C	79;84;89,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	283	1484	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3039	91.7	1	SNP	p	S87I	0	.	.	259	261	AGT	2334	2336	TCA	133;134;135	T;C;A,C	79;84;89,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	283	1484	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3039	91.7	1	SNP	p	S88P	0	.	.	262	264	TCC	2331	2333	AGG	135;132;131	A;G;G,A	93;90;89,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1098	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2922	76.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1595	1597	GGC	82;82;82	G;G;C	59;59;57	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1176	1178	GCA	119;121;122	G;C;A	77;78;77	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1179	1181	ATC	126;126;126	A;T;C	79;82;82	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1191	1193	GTG	132;132;132	G;T;G	84;84;83	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1191	1193	GTG	132;132;132	G;T;G	84;84;83	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1695	1697	ACC	96;95;95	A,G;C;C	55,1;64;65	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1749	1751	GCG	78;78;78	G;C,G;G	53;52,2;54	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1749	1751	GCG	78;78;78	G;C,G;G	53;52,2;54	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1872	1874	GGC	74;73;74	G;G;C,T	53;53;51,2	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1881	1883	GGC	69;70;69	G,T;G;C,G	48,1;48;47,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1190	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2195	101.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1899	1901	CCG	71;71;71	C,G;C;G,T	45,1;44;46,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	2100	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3214	119.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1783	1785	CTG	91;90;90	C,T;T;G,A	61,1;61;59,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	648	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2131	59.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	690	690	C	56	C	32	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	443	445	GGA	88;88;89	G;G;A	60;61;61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	F135L	NONSYN	403	405	TTT	704	706	CTT	54;57;57	C;T;T	42;43;44	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	R143G	NONSYN	427	429	AGA	728	730	GGA	64;64;64	G;G;A	45;44;44	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	D171G	NONSYN	511	513	GAT	812	814	GGT	84;83;83	G;G;T,G	63;62;61,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	G189S	NONSYN	565	567	GGC	866	868	AGC	91;91;90	A,C;G;C	59,1;59;58	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	932	932	T	95	T	66	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	1	SNP	p	G120K	0	.	.	358	360	GGT	659	661	GGT	64;64;63	G;G,T;T	46;45,1;47	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	1	SNP	p	A121D	0	.	.	361	363	GCC	662	664	GCC	63;63;63	G,A;C;C,A	44,1;46;46,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	612	porB1b	1035	1035	95.82	porB1b.l15.c4.ctg.1	1771	68.4	1	SNP	p	A121N	0	.	.	361	363	GCC	662	664	GCC	63;63;63	G,A;C;C,A	44,1;46;46,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2684	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4684	108.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1917	1919	AAT	125;124;124	A,G;A;T	87,1;88;88	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	202	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1219	33.8	1	SNP	p	V57M	1	.	.	169	171	ATG	670	672	ATG	83;81;83	A;T;G,A	55;54;54,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
